Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events.

bioRxiv : the preprint server for biology·2026
Same author

Exercise-associated microbial metabolites prevent skeletal muscle atrophy in adult female mice.

Nature communications·2026
Same author

APOE interacts with COX-2 on lipid droplets to modulate inflammatory lipid signaling.

bioRxiv : the preprint server for biology·2026
Same author

ApoE expression across the CNS: Who, What, Where, When, and How (much)?

Molecular neurodegeneration advances·2026
Same author

Lactate metabolism links reactive microglia, amyloid pathology, and Aβ dynamics.

Journal of neuroinflammation·2026
Same author

Protocol for stable isotope tracing of primary human peripheral blood mononuclear cells.

STAR protocols·2026

Related Experiment Video

Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Basic Science and Pathogenesis.

Lance A Johnson1

  • 1University of Kentucky, Lexington, KY, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

Replacing Apolipoprotein E4 (APOE4) with APOE2 in astrocytes or microglia reduces Alzheimer's disease amyloid pathology. Cell-type specific gene therapy targeting APOE offers a promising strategy for Alzheimer's disease treatment.

More Related Videos

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • The Apolipoprotein E (APOE) gene has different alleles (E2, E3, E4) influencing Alzheimer's disease (AD) risk.
  • Individuals with the APOE E4 allele have a significantly higher risk of developing late-onset AD.
  • APOE E2 allele carriers exhibit a substantially reduced risk for AD, highlighting its neuroprotective potential.

Purpose of the Study:

  • To investigate the therapeutic potential of replacing the AD-risk APOE E4 allele with the neuroprotective APOE E2 allele.
  • To determine the effects of cell-type specific APOE allele replacement (hepatocytes, astrocytes, microglia) on AD pathology.
  • To explore the underlying mechanisms of APOE allele replacement therapy.

Main Methods:

  • Utilized a novel transgenic APOE
  • switch mouse
  • (APOE4s2) model for in vivo APOE4 to APOE2 transition.
  • Assessed physiological and neuropathological changes following selective APOE allele replacement in hepatocytes, astrocytes, or microglia.
  • Employed mRNA, proteomic, single-cell transcriptomic, behavioral, and neuropathological analyses to evaluate the effects of the allelic switch.

Main Results:

  • Confirmed efficient APOE4 to APOE2 transition in target tissues upon tamoxifen induction.
  • Demonstrated that astrocyte- or microglia-specific APOE E4 to E2 replacement significantly reduces amyloid burden.
  • Observed distinct, cell-type specific alterations in the transcriptome and differential responses in gliosis and cognitive outcomes.

Conclusions:

  • Astrocyte- or microglia-specific APOE E4 to E2 replacement is sufficient to mitigate amyloid pathology in a mouse model.
  • The cellular response to AD pathology varies significantly based on the targeted cell type for APOE replacement.
  • These findings provide proof-of-concept for developing APOE-directed gene therapies for Alzheimer's disease.